Figures
Abstract
Objective
A meta-analysis was applied to evaluate the associations between tumor necrosis factor-α (TNF-α) −308G>A (rs1800629) polymorphism and type 2 diabetes mellitus (T2DM).
Methods
Hardy-Weinberg equilibrium (HWE) was employed to test genetic equilibrium among the genotypes of the selected literature. Power analysis was performed with the Power and Sample Size Calculation (PS) program. A fixed or random effect model was used on the basis of heterogeneity. Publication bias was quantified and examined with the Begg's funnel plot test and Egger's linear regression test. The meta-analysis was performed with Review Manager 5.1 and Stata 11.0.
Results
There were 10 studies including 1425 T2DM patients and 1116 healthy control subjects involved in this meta-analysis. No significant publication bias was found in the studies. The pooled ORs (95% CIs) for TNF-α −308G>A of A vs. G allele and GA+AA vs. GG genotype were 1.63 (1.17–2.25) and 1.47 (1.17–1.85), respectively.
Citation: Liu Z-h, Ding Y-l, Xiu L-c, Pan H-y, Liang Y, Zhong S-q, et al. (2013) A Meta-Analysis of the Association between TNF-α −308G>A Polymorphism and Type 2 Diabetes Mellitus in Han Chinese Population. PLoS ONE 8(3): e59421. https://doi.org/10.1371/journal.pone.0059421
Editor: Yi-Hsiang Hsu, Harvard Medical School, United States of America
Received: November 28, 2012; Accepted: February 14, 2013; Published: March 19, 2013
Copyright: © 2013 Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the National Natural Science Foundation of China (grant nos. 30830104, 31071166 and 81273166), Science and Technology Planning Project of Guangdong Province (grant no. 2009A030301004), Dongguan City Science and Technology Project (grant nos. 2011108101015, 2012105102010, 2012108102058) and the funds from Guangdong Medical College (grant nos. XG1001, XZ1105, STIF201121 and STIF201122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Diabetes mellitus (DM) has become a major health problem in the world. It is estimated that the population with DM will rise to 300 million in the year of 2025, and most of them are type 2 diabetes mellitus (T2DM) [1]. T2DM is a chronic complex disease with strong genetic components. It is well known that insulin resistance plays an important role in the development of T2DM. The pathogenesis of T2DM is generally considered being the results of interactions between multiple genetic susceptibility genes, and between genes and the environment [2]. Tumor necrosis factor-α (TNF-α) is a multifunctional cytokine produced by adipose tissue. It has been shown that TNF-α can affect insulin resistance by regulating adipocyte gene expression [3], [4], and that insulin resistance is an important pathophysiological mechanism of T2DM [5], [6].
So far, a number of studies [7]–[12] examining the association between TNF-α polymorphism and T2DM risk have been published in different countries. However, the findings from these studies are largely inconsistent. Particularly in China, the obvious contradictory results across different studies were obtained, rendering interpretation of its genetic risk at large for Han Chinese people difficult and confusing. Most studies of Han Chinese population focused on the association of TNF-α −308G>A, a genetic variant in the promoter region of this gene, with T2DM risk, because it may play an important regulatory role for TNF-α production. The schematic diagram of TNF-α −308G>A together with the location of the candidate SNP rs1800629 was shown in Figure 1.
In this graph, SNP rs1800629 locates on 5' upstream promoter region of TNF-α gene. “+1″ means the transcription initiation site, “ATG” represents the start codon, and “E1”, “E2”, “E3”, “E4” are 4 exons of TNF-α gene.
Nevertheless, the association between this polymorphism and T2DM susceptibility still remained unclear in Han Chinese population, with inconsistent findings across different studies. Since each single study was limited in providing sufficient information and adequate power for Han Chinese population, summarizing the results from these individual studies for obtaining a reliable and consolidated conclusion regarding TNF-α polymorphisms become essential. The aim of this meta-analysis was to integrate the findings from multiple studies to provide an overall assessment whether TNF-α −308G>A (rs1800629) polymorphism is associated with T2DM risk in a population of Han Chinese subjects.
Materials and Methods
Literature Databases
Major electronic literature databases were systematically searched, which included China National Knowledge Infrastructure (CNKI) database (http://www.cnki.net/), Chinese VIP database (http://www.cqvip.com/), Chinese Wanfang database (http://g.wanfangdata.com.cn/) and MEDLINE database (http://www.ncbi.nlm.nih.gov/pubmed), up to September 2012, for all publications about the association between TNF-α −308G>A polymorphism and T2DM in Han Chinese population. The keywords in this search were consisted of TNF-α, type 2 diabetes mellitus, polymorphism and Chinese/China.
Selection Criteria
To be included in this meta-analysis, studies must meet the following criteria: case-control studies, available genotypic and allelic data or summarized frequencies, Chinese Han as the studied subjects, and the diagnosis of T2DM patients based on the 1999 WHO Diabetes Criteria (e.g., with fasting plasma glucose concentration of the subjects above 7.0 mmol/L were diagnosed as diabetes) [13]. If there were multiple publications from the same study group, the most recent study was included in this meta-analysis. However, if the study was a review, lecture, editorial or correspondence letter, it was excluded. Also, Hardy-Weinberg equilibrium (HWE) was checked for each study and the studies whose healthy control groups failed HWE were also excluded (to limit heterogeneity and ensure quality of data). Study quality was assessed using the guidelines for case-control studies [14]. Due to the criteria developed by Clark et al [15], a quality assessment score (as implemented in [16]–[18]) was estimated for the quality of each association study based on traditional epidemiological and genetic considerations. Using a 10-point scoring system, studies were scored as “good” if the score was 8 to 10, “moderate” if the score was 5 to 7 and “poor” if the score was less than 4 [19].
Data Extraction
Two reviewers independently extracted data from relevant studies, including author, year of publication, geographic region, genotype distribution for T2DM patients and healthy control subjects, descriptive statistics on each study (e.g., gender, age, body mass index, total cholesterol, and triglyceride etc.) and P-values of HWE test in healthy control groups. Then, a group discussion was conducted to remedy any discrepancies in data collected by different reviewers.
Statistical Analysis
This meta-analysis was performed with Review Manager 5.1 and Stata 11.0. Power analysis was performed using the Power and Sample Size Calculation (PS) program (http://biostat.mc.vanderbilt.edu/wiki/Main/PowerSampleSize) [20]. Heterogeneity among studies was examined with χ2-based Q statistic [21]. If there was statistically significant heterogeneity among studies (P<0.05), a random effect model (Dersimonian-Laird method) was selected to merge data. Otherwise, a fixed effect model (Mantel-Haenszel method) was employed to analyze data. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the association between −308G>A of TNF-α and T2DM risk. Then, publication bias was estimated by Begg's funnel plot test and Egger's linear regression test. Finally, sensitivity analysis was performed to assess the influence of each individual study.
Results
Characteristics of Eligible Studies
At first, 11 studies of the association between TNF-α −308G>A (rs1800629) polymorphism and T2DM susceptibility in Han Chinese were identified. Then, one study [22] was excluded since it significantly deviated from HWE in healthy control group (P<0.05). Hence, there were actually 10 studies [23]–[32] to be used in this meta-analysis, with a total of 1425 patients of T2DM and 1116 healthy control subjects. The characteristics of the included studies were summarized in Table 1. Among these studies, eight were from Chinese Mainland, and the other two from Hong Kong. The mean age of all the subjects ranged from 36.1 to 60.5 years, and the gender was not evenly distributed in the 10 studies. Moreover, not all of the included studies were adjusted for covariates, such as body mass index, total cholesterol, triglyceride and so on. As a result, the information for these covariates was not shown in Table 1. The quality for these studies was rated to be moderate or above according to the quality assessment scores calculated.
Power Analysis
Before this meta-analysis, power analysis was performed by using the PS program to prove whether the selected studies could offer adequate power. With data provided by the 10 studies, Mantel-Haenszel test, assuming that each 2×2 table consists of cases and controls selected from a different stratum that is defined by studies, could provide the power of 0.996 and 0.916 under the allelic and dominant genetic models, respectively.
Association between TNF-α −308G>A and T2DM
There was statistically significant allelic heterogeneity among the included studies (P = 0.03). Therefore, for estimating the overall allelic risk, a random effect model was selected to merge data. Figure 2 showed the ORs (95% CIs) estimate of TNF-α −308G>A (A vs. G allele) for each study and the overall estimate for the pooled data. The overall allelic OR (95% CI) was 1.63 (1.17–2.25), indicating that this allele brought a modest-size allelic risk of diabetes to Han Chinese population.
Association between genotypes (GA+AA vs. GG genotype) at TNF-α −308G>A locus and T2DM were further analyzed. Heterogeneity testing revealed that heterogeneity among the eligible studies was not statistically significant (P = 0.06). Hence, a fixed effect model was employed to analyze data. The pooled OR (95% CI) for TNF-α −308G>A under the dominant model (GA+AA vs. GG genotype) was 1.47 (1.17–1.85) (Figure 3), also interpreted to be a modest-size risk of diabetes.
Publication Bias
Begg's funnel plot test and Egger's linear regression test were performed to assess any publication bias. The funnel plots of the association between T2DM and TNF-α −308G>A for A vs. G allele and GA+AA vs. GG genotype were shown in Figures 4 and 5, respectively. The P-values for Begg's test of TNF-α −308G>A A vs. G allele and GA+AA vs. GG genotype were 0.531 and 0.180, respectively, and the P-values for Egger's linear regression test were 0.323 and 0.123, respectively (Table 2). The shapes of the two funnel plots were symmetrical at large, and there were no statistical significance based on the P-values of Begg's test and Egger's linear regression test, suggesting no evidence of publication bias among the included studies.
Sensitivity Analysis
Finally, a sensitivity analysis was performed to evaluate the influence of individual studies. A leave-one-out procedure (i.e., omitting one study at a time) was used to estimate the contribution of a single study to the pooled OR value. This sensitivity analysis demonstrated that none of the studies influenced the pooled OR greatly. The leave-one-out ORs estimate ranged from 1.46 (1.08–1.96) to 1.72 (1.19–2.48) for A vs. G allele, and 1.37 (1.08–1.75) to 1.61 (1.24–2.10) for GA+AA vs. GG genotype, respectively, suggesting that the pooled estimates of allelic and genotypic risks obtained in this study were both stable and reliable.
Discussion
TNF-α gene, situated on human chromosome 6p21.3, encodes a multifunctional proinflammatory cytokine, which plays the most important role in the development of T2DM. It has been well documented that high expression of TNF-α in adipose tissue is related to insulin resistance, considered to be an important pathogenic mechanism for the development of T2DM [33].
Recently, a number of candidate-gene studies for diabetes in Han Chinese population have been reported, and the association between TNF-α −308G>A (rs1800629) and T2DM is a hot focus. By searching literature, we found that the findings regarding this association were of obvious discrepancies across different studies. Hence, it is highly demanded to systematically assess the association of TNF-α −308G>A with T2DM prior to translation of this genetic finding into clinical practice.
To the best of our knowledge, this study was the first meta-analysis to comprehensively examine the association between TNF-α −308G>A and T2DM in Han Chinese population, and the pooled data from 10 eligible studies contained 1425 T2DM patients and 1116 healthy subjects. This meta-analysis showed that there was statistically significant association between TNF-α −308G>A polymorphism and T2DM risk in Han Chinese population, demonstrating that TNF-α −308G>A was an important risk factor for T2DM in Han Chinese population. This conclusion is largely consistent with a previous meta-analysis examining this association in Asian populations [34]. However, the worldwide meta-analysis of the studies of very different ethnical populations (divided into Asian, European and others), performed by Feng RN et al. [35], indicated that TNF-α −308G>A gene polymorphism was not associated with T2DM risk in these large racial divisions. These discrepancies suggest that the genetic effect of TNF-α −308G>A is race-specific. While it imposes a significant risk on Han Chinese population, TNF-α −308G>A polymorphism might not be associated with T2DM risk in other racial populations such as Caucasians [7], [12], [36], [37], Japanese [38], [39] and Indians [40]. In addition to ethnic differences, a list of epidemiological and design factors (e.g., gender, age, life style, study design or limited sample size) may explain the contradictory results obtained in different studies as well.
To avoid potential racial admixture, we restricted our analysis to Han Chinese in this study. All of the 10 included studies were of Han Chinese ancestry. Nevertheless, for Han Chinese population who live in a vast country, geographical and culture differences might be additional factors causing genetic heterogeneity. In this meta-analysis, five of the included studies were from northern China, and the remaining five from southern China. The culture and habits, such as personality, diet, living environment, customs and so on, in these two large geographic areas, were very different, and the genetic communications between these two geographic areas might not be as frequently as within each geographic area, which may lead to population stratification. The fact that significant between-study heterogeneity in allelic association and marginal significance in genotypic association across the 10 studies might support our perspective. Other factors (e.g., age, sex, sample size, genotyping method, gene-gene and gene-environment interactions) might contribute to heterogeneity as well. Unfortunately, due to limited number of studies and lack of size of samples, we did not perform any stratified analysis regarding these potential confounding factors.
Finally, we should recognize several limitations of this study. First, we did not take into account the impact of several covariates (the potential confounding factors) on the results of this meta-analysis due to incomplete data for several studies. Second, because of lack of the data for individuals’ environmental exposures, we did not further explore the interactions of TNF-α gene with various environmental factors. Finally, only single SNP (rs1800629) in TNF-α gene was analyzed in this study, and whether additional genetic variants of either functional or polymorphic contribute to this gene remains unclear, which may lead to underestimation of its overall genetic effect on T2DM susceptibility. Thus, constructing its spectrum of genetic variants is required for comprehensive assessment of its role in conferring susceptibility to T2DM.
In conclusion, by systematically integrating 10 well-characterized association studies for Han Chinese, with 1425 T2DM patients and 1116 healthy subjects, we found that TNF-α −308G>A (rs1800629) polymorphism were statistically significantly associated with T2DM in Han Chinese population, suggesting that A allele at this locus increases the risk for the development of T2DM in this population. However, in our view, more large-scale independent studies or larger sample sizes are still needed to consolidate this finding in the future. Furthermore, for a complex disease like T2DM, which is considered being the result of the sophisticated interplays between multiple genes, and their interactions with environment, a rational and extended research is to further identify the genes and environmental triggers interacting with TNF-α −308G>A and the functional involvement of this polymorphism leading to the molecular pathogenesis of T2DM.
Supporting Information
Figure S1.
PRISMA flow diagram of including studies.
https://doi.org/10.1371/journal.pone.0059421.s001
(DOC)
Checklist S1.
PRISMA checklist of the association between TNF-α −308G>A and T2DM.
https://doi.org/10.1371/journal.pone.0059421.s002
(DOC)
Author Contributions
Conceived and designed the experiments: ZL YD SR DK. Performed the experiments: ZL LX HP. Analyzed the data: ZL LX WL. Contributed reagents/materials/analysis tools: ZL YD YL SZ HP WL. Wrote the paper: ZL YD SR.
References
- 1. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414–1431.
- 2. Mayer EJ, Newman B, Austin MA, Zhang D, Quesenberry CP Jr, et al. (1996) Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins. Am J Epidemiol 143: 323–332.
- 3. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 94: 1543–1549.
- 4. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87–91.
- 5. Nolan CJ, Damm P, Prentki M (2011) Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378: 169–181.
- 6. Saini V (2010) Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes 1: 68–75.
- 7. Boraska V, Rayner NW, Groves CJ, Frayling TM, Diakite M, et al. (2010) Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes. BMC Med Genet 11: 69.
- 8. Guzman-Flores JM, Munoz-Valle JF, Sanchez-Corona J, Cobian JG, Medina-Carrillo L, et al. (2011) Tumor necrosis factor-alpha gene promoter −308G/A and -238G/A polymorphisms in Mexican patients with type 2 diabetes mellitus. Dis Markers 30: 19–24.
- 9. Li H, Groop L, Nilsson A, Weng J, Tuomi T (2003) A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes. J Clin Endocrinol Metab 88: 2767–2774.
- 10. Perez-Luque E, Malacara JM, Garay-Sevilla ME, Fajardo ME (2012) Association of the TNF-alpha −308G/A polymorphism with family history of type 2 diabetes mellitus in a Mexican population. Clin Biochem 45: 12–15.
- 11. Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, et al. (2003) A polymorphism in the promoter of the tumor necrosis factor-alpha gene (−308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 167: 257–264.
- 12. Zeggini E, Groves CJ, Parkinson JR, Halford S, Owen KR, et al. (2005) Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes. Diabetologia 48: 2013–2017.
- 13. Grimaldi A, Heurtier A (1999) [Diagnostic criteria for type 2 diabetes]. Rev Prat 49: 16–21.
- 14. Lichtenstein MJ, Mulrow CD, Elwood PC (1987) Guidelines for reading case-control studies. J Chronic Dis 40: 893–903.
- 15. Clark MF, Baudouin SV (2006) A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med 32: 1706–1712.
- 16. Attia J, Thakkinstian A, D'Este C (2003) Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 56: 297–303.
- 17. Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, et al. (2011) Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 54: 2303–2314.
- 18. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, et al. (2005) Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162: 201–211.
- 19. Srivastava K, Srivastava A, Sharma KL, Mittal B (2011) Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res 728: 67–79.
- 20. Dupont WD, Plummer WD Jr (1998) Power and sample size calculations for studies involving linear regression. Control Clin Trials 19: 589–601.
- 21. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820–826.
- 22. Shiau MY, Wu CY, Huang CN, Hu SW, Lin SJ, et al. (2003) TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients. Tissue Antigens 61: 393–397.
- 23. Chen J, Pan L, Zhao XF, Chai L, Wei YL, et al. (2009) Relationship between tumor necrosis factor-α G-308A polymorphism and type 2 diabetes mellitus. Ningxia Medical Journal 31: 395–396.
- 24. Ko GT, Lee SC, Pu YB, Ng MC, So WY, et al. (2003) Tumour necrosis factor-alpha promoter gene polymorphism at - 308 (genotype AA) in Chinese subjects with Type 2 diabetes. Diabet Med 20: 167–168.
- 25. Lee SC, Pu YB, Thomas GN, Lee ZS, Tomlinson B, et al. (2000) Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism 49: 1021–1024.
- 26. Liu HL, Lin YG, Wu J, Sun H, Gong ZC, et al. (2008) Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes. Eur J Clin Pharmacol 64: 663–671.
- 27. Pan HY, Zhang PX, Ni FY, Li Q (2006) Association between tumor necrosis factor-alpha-308 G/A polymorphism and type 2 diabetes mellitus. Chinese Journal of Clinical Rehabilitation 10: 72–74.
- 28. Ren RZ, Chen GR, Cai JF, Tao G, Li YJ (2003) Association between tumor necrosis factor-α gene polymorphism and insulin resistance in type 2 diabetes mellitus. Chnesse Journal of Endocrinology and Metabolism 19: 271–274.
- 29. Sun B, Wang BL, Liang DC, Zuo AJ, Guo G, et al. (2006) The correlation of TNF-α and insulin resistance in type 2 diabetes. Journal of Tianjin Medical University 12: 424–426.
- 30. Wang LL, Du ZW, Liu JN, Wu M, Song Y, et al. (2012) Association of UCP3, APN, and TNF-α Gene Polymorphisms with Type 2 Diabetes in a Population of Northern Chinese Han Patients. Chem Res Chinese Universities 28: 255–258.
- 31. Wang ZJ, Zhou YR, Zhi ZJ, Pang JH, Wang Y (2005) Study on tumor necrosis factor-α promotor gene polymorphism with type 2 diabetes mellitus. Chin J Intern Med 44: 214–215.
- 32. Zhang PA, Chen H, Li Y, Wen ZY (2003) Study on the association of tumor necrosis factor-α gene polymorphism with NIDDM. Chinese Journal of Clinical Laboratory Science 21: 146–149.
- 33. OuYang Y, Wang PF (2006) Recent progress on relationship between adipose cell cytokine and insulin resistance. Medical Recapitulate 12: 229–232.
- 34. Wu N, Zhou LL, Guo D, Wang Y, Han P (2010) Association of the promoter polymorphism of tumor necrosis factor alpha 308 G/A gene with the type 2 diabetes mellitus: a Meta-analysis. Chinese Journal of Practical Internal Medicine 30: 927–929.
- 35. Feng RN, Zhao C, Sun CH, Li Y (2011) Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes mellitus. PLoS One 6: e18480.
- 36. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS (1995) Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211: 833–839.
- 37. Mustapic M, Popovic Hadzija M, Pavlovic M, Pavkovic P, Presecki P, et al. (2012) Alzheimer's disease and type 2 diabetes: the association study of polymorphisms in tumor necrosis factor-alpha and apolipoprotein E genes. Metab Brain Dis 27: 507–512.
- 38. Furuta M, Yano Y, Ito K, Gabazza EC, Katsuki A, et al. (2002) Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 56: 141–145.
- 39. Ishii T, Hirose H, Saito I, Nishikai K, Maruyama H, et al. (2000) Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men. Metabolism 49: 1616–1618.
- 40. Mukhopadhyaya PN, Acharya A, Chavan Y, Purohit SS, Mutha A (2010) Metagenomic study of single-nucleotide polymorphism within candidate genes associated with type 2 diabetes in an Indian population. Genet Mol Res 9: 2060–2068.